Outcomes of Bilateral Cataract Surgery in Infants 7 to 24 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
02 2021
Historique:
received: 16 04 2020
revised: 09 06 2020
accepted: 09 07 2020
pubmed: 18 7 2020
medline: 31 7 2021
entrez: 18 7 2020
Statut: ppublish

Résumé

To evaluate outcomes of bilateral cataract surgery in children aged 7 to 24 months and compare rates of adverse events (AEs) with other Toddler Aphakia and Pseudophakia Study (TAPS) registry outcomes. Retrospective clinical study at 10 Infant Aphakia Treatment Study (IATS) sites. Statistical analyses comparing this cohort with previously reported TAPS registry cohorts. Children enrolled in the TAPS registry between 2004 and 2010. Children underwent bilateral cataract surgery with or without intraocular lens (IOL) placement at age 7 to 24 months with 5 years of postsurgical follow-up. Visual acuity (VA), occurrence of strabismus, AEs, and reoperations. A total of 40 children (76 eyes) who underwent bilateral cataract surgery with primary posterior capsulectomy were identified with a median age at cataract surgery of 11 months (7-23); 68% received a primary IOL. Recurrent visual axis opacification (VAO) occurred in 7.5% and was associated only with the use of an IOL (odds ratio, 6.10; P = 0.005). Glaucoma suspect (GS) was diagnosed in 2.5%, but no child developed glaucoma. In this bilateral cohort, AEs (8/40, 20%), including glaucoma or GS and VAO, and reoperations occurred in a similar proportion to that of the published unilateral TAPS cohort. When analyzed with children aged 1 to 7 months at bilateral surgery, the incidence of AEs and glaucoma or GS correlated strongly with age at surgery (P = 0.011/0.004) and glaucoma correlated with microcornea (P = 0.040) but not with IOL insertion (P = 0.15). Follow-up to age 5 years after bilateral cataract surgery in children aged 7 to 24 months reveals a low rate of VAO and very rare glaucoma or GS diagnosis compared with infants with cataracts operated at < 7 months of age despite primary IOL implantation in most children in the group aged 7 to 24 months. The use of an IOL increases the risk of VAO irrespective of age at surgery.

Identifiants

pubmed: 32679160
pii: S0161-6420(20)30682-5
doi: 10.1016/j.ophtha.2020.07.020
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

302-308

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000135
Pays : United States

Informations de copyright

Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Erick D Bothun (ED)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota; Department of Ophthalmology and Visual Neurosciences, Minneapolis, University of Minnesota, Minnesota. Electronic address: Bothun.Erick@mayo.edu.

M Edward Wilson (ME)

Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina.

Kimberly G Yen (KG)

Departments of Ophthalmology and Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.

Jill S Anderson (JS)

Department of Ophthalmology and Visual Neurosciences, Minneapolis, University of Minnesota, Minnesota.

Natalie C Weil (NC)

Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.

Allison R Loh (AR)

Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon.

David Morrison (D)

Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.

Sharon F Freedman (SF)

Departments of Ophthalmology and Pediatrics, Duke University Medical Center, Durham, North Carolina.

David A Plager (DA)

Department of Ophthalmology, Indiana University, Indianapolis, Indiana.

Deborah K Vanderveen (DK)

Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.

Elias I Traboulsi (EI)

Department of Pediatric Ophthalmology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.

David O Hodge (DO)

Department Health Sciences Research, Mayo Clinic, Jacksonville, Florida.

Scott R Lambert (SR)

Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon; Departments of Ophthalmology and Pediatrics, Stanford University Medical Center, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH